RNA, U4 small nuclear 50, pseudogene (RNU4-50P)

RNU4-50P is a documented pseudogene, part of the U4 snRNA-related family[1]. Pseudogenes are non-functional copies of genes, often formed by gene duplication or retrotransposition, and do not produce active RNA or protein products. Unlike active small nuclear RNAs (such as RNU4-2), which play a critical role in pre-mRNA splicing as components of the spliceosome, RNU4-50P has no known cellular function, disease association, or therapeutic application[1]. Recent genetic research and clinical relevance center on functional snRNAs like RNU4-2, which are strongly implicated in neurodevelopmental disorders through disruption of splicing, not on pseudogenes like RNU4-50P[2][4][6][7]. Summary of key points: - RNU4-50P is not a therapeutic target. - It is a pseudogene with no known function, disease role, or drug associations. - Information may be incorrectly attributed if seeking a therapeutic or functional RNA target—the correct disease-associated gene is usually RNU4-2[2][4][6][7]. - Use caution when referencing RNU4-50P for clinical or pharmacological purposes. For structured knowledge bases or target lists, exclude RNU4-50P as a functional target. Focus on the active U4 snRNA genes if relevant to splicing or neurodevelopmental disorders.

Other names

U4 Small Nuclear RNA pseudogene 50RNU4-50P